Athena on Boards | Cohort 6
March 2021- July 2021

POWERED BY COOLEY

DAWN BLESSING

VP, Scientific Strategy & Corporate Development | Zogenix

LISA BROCKMAN

SVP, Accounting & Corporate Controller | Mitchell International

LAURA CARTER

Chief Scientific Officer | Gossamer Bio

 

ANILA DHOKIA
VP, Internal Audit & ERM | Illumina

 

AMBREEN FAROOK

Sr. Director, Alliance Management & Program Lead | Halozyme

 

MONIQUE LEVY
Chief Commercial & Strategy Officer | Woebot Health

 

SHERI OLSON

Sr. Director Product Management, Applications, & Services | Thermo Fisher Scientific

 

LISA PECORA

VP, Global Finance | NuVasive

 

JENNY REGAN

CEO | Key Tech

 

SARAH RICHARDS

Consultant & Science Journalist | Bristol Myers Squibb

 

EIRY ROBERTS

Chief Medical Officer | Neurocrine Biosciences

 

CHRISTINE SHAW

VP, Assay Development | Genmark Diagnostics

 

CARRIE (ARIEL) THOMAS

Sr. Manager, Global Market Development | Thermo Fisher Scientific

CARLA VALLONE

President | Portavoce PR

 

CLAIRE WESTON

Founder & CEO | Reveal Biosciences

HOLLIS WINKLER

VP, Human Resources | Genmark Diagnostics

 

DANA ZHANG

VP, Finance & Corporate Secretary | Ambrx Inc.

Contact Athena CEO, Holly Smithson to secure your spot on the waitlist

for the next cohort and design your board search through Athena’s On Boards Series.

Athena on Boards Mentors

TERRY BAYER

Chief Operations Officer | Upfront Resolution

JAYE CONNOLLY-LABELLE

CEO | RippleNami Inc.

KAREN POSSEMATO

VP, Corporate Marketing & Communications | Seer


Athena on Boards Committee

CO-CHAIR: JAYE CONNOLLY-LABELLE

CEO | RippleNami Inc.

CO-CHAIR: CHARITY WILLIAMS

Partner | Cooley

SHIRIN ALIPANAH

Head of IT Program Office | Jack In The Box

GRACE CHUI-MILLER

Chief Financial Officer | Correlation Ventures

BO MONACO

Audit Partner | BDO